Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Oct 16;5(4):2675-700.
doi: 10.3390/biom5042675.

Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease

Affiliations
Review

Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease

Wojciech Bobela et al. Biomolecules. .

Abstract

Accumulation and misfolding of the alpha-synuclein protein are core mechanisms in the pathogenesis of Parkinson's disease. While the normal function of alpha-synuclein is mainly related to the control of vesicular neurotransmission, its pathogenic effects are linked to various cellular functions, which include mitochondrial activity, as well as proteasome and autophagic degradation of proteins. Remarkably, these functions are also affected when the renewal of macromolecules and organelles becomes impaired during the normal aging process. As aging is considered a major risk factor for Parkinson's disease, it is critical to explore its molecular and cellular implications in the context of the alpha-synuclein pathology. Here, we discuss similarities and differences between normal brain aging and Parkinson's disease, with a particular emphasis on the nigral dopaminergic neurons, which appear to be selectively vulnerable to the combined effects of alpha-synuclein and aging.

Keywords: Parkinson’s disease; aging; alpha-synuclein; metabolism; mitochondria; nigral dopaminergic neurons; proteostasis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Physiological and pathological roles of α-synuclein. Alpha-synuclein, in physiological conditions, is considered to exist in two forms, monomer and tetramer. Its role in neuronal homeostasis is mostly associated with molecular chaperone activity at the synapse, where it controls clustering [39,40,41] and release of synaptic vesicles [33,34,42], and at the mitochondrial membrane, where together with cardiolipin, it stabilizes electron transport chain proteins [47]. When misfolded and/or aggregated, α-synuclein inhibits the ubiquitin-proteasome system [52,53,54,55] as well as mitochondrial complex I activity [43,56,57], blocks mitochondrial fusion [58,59] and impairs autophagy [60,61,62].
Figure 2
Figure 2
The effect of aging on dopamine neurons. During aging, dopamine neurons of the substantia nigra pars compacta undergo a series of debilitating molecular changes, which compromise their physiological function. With time, a decrease in mitochondrial turnover occurs. As a consequence of this, accumulation of dysfunctional mitochondria is observed, which results in an increase in reactive oxygen species production [29]. Ubiquitin-proteasome and autophagic activities gradually decline with time [27,28], which leads to the deposition of neuronal pigments like neuromelanin or lipofuscin [114]. Aging has been correlated to a significant increase in protein levels of α-synuclein, promoting misfolding and neuronal toxicity [111].

References

    1. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science. 1997;276:2045–2047. doi: 10.1126/science.276.5321.2045. - DOI - PubMed
    1. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., Riess O. Ala30pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease. Nat. Genet. 1998;18:106–108. doi: 10.1038/ng0298-106. - DOI - PubMed
    1. Zarranz J.J., Alegre J., Gomez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atares B., et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 2004;55:164–173. doi: 10.1002/ana.10795. - DOI - PubMed
    1. Appel-Cresswell S., Vilarino-Guell C., Encarnacion M., Sherman H., Yu I., Shah B., Weir D., Thompson C., Szu-Tu C., Trinh J., et al. Alpha-synuclein p.H50q, a novel pathogenic mutation for Parkinson’s disease. Mov. Disord. 2013;28:811–813. doi: 10.1002/mds.25421. - DOI - PubMed
    1. Kiely A.P., Asi Y.T., Kara E., Limousin P., Ling H., Lewis P., Proukakis C., Quinn N., Lees A.J., Hardy J., et al. Alpha-synucleinopathy associated with G51D SNCA mutation: A link between Parkinson's disease and multiple system atrophy? Acta Neuropathol. 2013;125:753–769. doi: 10.1007/s00401-013-1096-7. - DOI - PMC - PubMed

Publication types

Substances